Combination of motesanib, taxane, and platinum-containing anticancer agents for use in the treatment of non-small cell lung cancer in a subset of the population

摘要

The present invention provides a method of improving survival associated with cancer in a subset of the general population. The invention provides a method of improving survival associated with cancer in patients of Asian ethnic background. In addition, the present application relates to the treatment of angiogenesis related disease in an Asian patient with kinase inhibitors. In addition the present application relates to the treatment of non-small cell lung cancer in an Asian patient with motesanib.